Compare Enzyme (MLN) vs MVL (MVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs MVL — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while MVL trades at Rp16.38 (market cap Rp472,56M, Rp1,47M 24h volume). The key difference: MVL is far larger — about 3.5× Enzyme's market cap, and MVL's supply is capped (27,8B / 30B MVL (93%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and MVL for 58 Days on average.
| MLN | MVL | |
|---|---|---|
Market Cap | Rp134,13M | Rp472,56M |
Volume (24h) | Rp104,56M | Rp1,47M |
Circulating Supply | 3,3M MLN | 27,8B / 30B MVL (93%) |
Typical Hold Time | 29 Days | 58 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
MVL is a cryptocurrency with a market cap of Rp472,56M and a circulating supply of 27,8M tokens out of a 30M max supply, indicating 93% circulation. The average hold time is 58 days. Current price data is unavailable for technical analysis. No recent protocol updates or ecosystem news were identified, suggesting a period of stability or low development activity.
The outlook is neutral with low liquidity as a primary risk. The main opportunity lies in the high circulation rate, which may reduce inflationary sell pressure. Major risks include market volatility due to low trading volume and the absence of recent fundamental developments to drive value.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About MVL
MVL, which stands for Mobility Value Lab, is an innovative project that combines the fields of mobility and blockchain technology. The primary goal of MVL is to share data value among all participants in its ecosystem. This integration is accomplished using various blockchain protocols that are designed to enhance the development of mobility services.
Read more on MVL →
